SPRY Therapeutics secured $15 million in funding to fuel its rapid expansion across the United States. This latest round, spearheaded by Flourish Ventures, Together Fund, and Fidelity’s Eight Roads and F-prime Capital, brings SPRY’s total funding to $25 million since its 2021 launch.
SPRY offers an AI-powered, billing-centric platform that integrates all aspects of clinic management. It integrates clinical, finance, and administrative functions and automates the operationally intensive billing process while addressing patient engagement, customised data entry, and report generation. vIt limits the time therapists are on the computer, minimising accounts receivable and maximising revenue per visit, thereby increasing efficiency at the front desk.
The company has partnered with over 105 US clinics across 30 states. It was named the top physical therapy software solution by G2 in the Summer and Fall editions, the number-one SaaS recommendation site based on authenticated user reviews.